Phaseline

Targets › RPLB

RPLB: drug programs, companies and trials

2 programs from 1 company in 2 trials: 2 Phase 2; Infectious disease.

Open in Phaseline: the race on RPLB, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Assistance Publique - Hôpitaux de ParisLinezolid
Bacterial 70S ribosome inhibitor
RPLBPhase 2Tuberculosis–
Assistance Publique - Hôpitaux de ParisTedizolid
Bacterial 70S ribosome inhibitor
RPLBPhase 2Tuberculosis–

Conditions

Tuberculosis (2)

Modalities

small molecule (2)

Companies

Assistance Publique - Hôpitaux de Paris (2)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.